GenMont Biotech Announcement of Shareholders' Meeting Resolution to Permit Directors to Engage in Competitive Business
AI Summary (NQ-processed)
GenMont Biotech's shareholders' meeting resolved to permit directors to engage in competitive business, including Chairman Chen Gen-de and six others to hold concurrent positions in subsidiaries or other companies for a period from June 30, 2026 to June 29, 2029.
AI Analysis
Frequently Asked Questions
Q: When was this resolution passed?
A: At the shareholders' meeting on June 8, 2026.
Q: How long is the permission period?
A: From June 30, 2026 to June 29, 2029, three years.
Q: Where is the China subsidiary located?
A: No. 19 Guangyuan Road, Wuqing Development Zone, Tianjin.